Scopus BioPharma Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2020 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Scopus BioPharma Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2020 to Q4 2022.
  • Scopus BioPharma Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2022 was $0.000.
Unrecognized Tax Benefits, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $0 $0 Dec 31, 2022 10-K 2023-04-14
Q4 2021 $0 $0 Dec 31, 2021 10-K 2023-04-14
Q4 2020 $0 Dec 31, 2020 10-K 2022-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.